Jubilant Life Sciences Limited has entered into Stock Purchase Agreement on November 29, 2018 for acquiring 534,194 shares of Common Stock of Inipharm Inc., USA.
Time period for the acquisition : Three months
Cost of acquisition : USD 534.20 (USD Five Hundred Thirty Four and Twenty cents only)
Brief background about the entity
- Products/line of business: Drug Discovery and Development
- Date of incorporation: July 23, 2018
- Country in which Inipharm Inc. has presence: USA
- Any other significant information: NIL